G. Villanova

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 272 citations · Full text

Avp V2, Immunology, Pharmacotherapy +18

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

N. Tubiana-Mathieu, Philippe Bougnoux, D. Becquart et al. · British Journal of Cancer · 2009 · 46 citations · Full text

Effects of SR 49059, a non‐peptide antagonist of vasopressin V_1areceptors, on vasopressin‐induced coronary vasoconstriction in conscious rabbits

C. Serradeil‐Le Gal, G. Villanova, Michel Boutin et al. · Fundamental and Clinical Pharmacology · 1995 · 19 citations

[Anti-edematous action of a hexane extract of the stone fruit of Serenoa repens Bartr].

Tarayre Jp, André Delhon, H Lauressergues et al. · PubMed · 1983 · 19 citations

Food Chemistry, Stone Fruit, Food Bioactive Compound +5

Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial)

Matti Aapro, Manuel Ruíz‐Borrego, Roberto Hegg et al. · The Breast · 2019 · 18 citations

Breast Oncology, Oncology, Medicine +11